La Nación, a prominent Costa Rican newspaper, shared updates on February 17, 2026, regarding social assistance payments, medical treatments for hair loss in women, and advancements in male contraception.
At 00:31 UTC on February 17, La Nación announced that IMAS had confirmed the deposit date for subsidies in February 2026: ” IMAS confirma la fecha de depósito de los subsidios en febrero 2026 https://t.co/3iWVeJUpNJ”.
Shortly after, at 00:37 UTC, the outlet addressed the use of minoxidil in women for treating alopecia and its actual effects: ” Minoxidil en mujeres: qué hace contra la alopecia y cuáles son sus efectos reales https://t.co/LHlT6zGmlQ”.
Later that morning at 00:41 UTC, La Nación reported on a scientific breakthrough related to male contraception. The tweet stated: ” Descubrimiento de ‘interruptor’ molecular abre la puerta a anticonceptivo masculino no hormonal https://t.co/FaU4KrSqk1″.
IMAS (Instituto Mixto de Ayuda Social) is responsible for administering various social welfare programs in Costa Rica. Its subsidy disbursements provide financial support to vulnerable populations. Minoxidil is an FDA-approved topical treatment widely used to address hair loss and is prescribed to both men and women experiencing androgenetic alopecia. Recent research into non-hormonal male contraceptives has focused on molecular mechanisms that could offer alternatives to existing hormonal methods.
